This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
AXP Q4 Earnings Lag Estimates on Rising Customer Engagement Costs
by Zacks Equity Research
American Express posts Q4 EPS growth and a revenue beat, but higher customer engagement and operating costs drag results despite strong Card Member spending.
AXPNegative Net Change CBOENegative Net Change TRUPNegative Net Change SKWDNegative Net Change
earnings fin-tech finance payments
PGY vs. OMF: Which Stock Wins the Consumer Credit Battle?
by Nikita Kataruka
Can Pagaya's AI-powered, capital-light platform outshine a traditional non-prime rival like OneMain on growth potential? Let us find out.
OMFNegative Net Change PGYNegative Net Change
fin-tech finance
PayPal Plunges 23.3% in 3 Months: Time to Buy, Sell or Hold the Stock?
by Rohit Vasant Fatarpekar
PYPL shares slide 23.3% in three months as competition, tariffs and higher expenses bite. Yet new platforms, AI commerce and Venmo growth provide relief.
MANegative Net Change VNegative Net Change PYPLNegative Net Change
fin-tech
Simmons First National (SFNC) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SFNCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy First Bancorp (FBP) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
FBPNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Does Pagaya's Asset-Light Strategy Help Reduce Credit Risk?
by Nikita Kataruka
PGY's asset-light model keeps most loans off its balance sheet, using ABS and forward flows to curb credit risk and stay resilient in volatile markets.
TREENegative Net Change UPSTNegative Net Change PGYNegative Net Change
fin-tech finance
Grupo Aeroportuario del Sureste (ASR) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ASRNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Align Technology (ALGN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ALGNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
SOFI Technologies to Report Q4 Earnings: Here's What to Expect
by Zacks Equity Research
SOFI heads into Q4 earnings with strong revenue growth expectations and a solid track record of beating estimates.
ALVNegative Net Change ADNTNegative Net Change SOFINegative Net Change
fin-tech finance
SoFi vs. OppFi: Which Fintech Stock Looks More Compelling Right Now?
by Shuvra Shankar Dey
SOFI's expanding platform, blockchain payments, AI tools and Galileo integration strengthen its edge over OPFI in fintech lending.
SOFINegative Net Change OPFINegative Net Change
fin-tech finance